High-dose chemotherapy (HDCT) with G-CSF support before radiotherapy (RT) in malignant gliomas (MG):: Phase II trial

被引：0
|
作者：
Viñolas, N
Gil, M
Verger, E
Villá, S
Pujol, T
Caral, L
García, M
Graus, F
Estapé, J
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Inst Catala Oncol, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80869-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
435
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [41] High-dose proton beam radiotherapy of hepatocellular carcinoma: Preliminary results of a phase II trial
    Bush, DA
    Hillebrand, DJ
    Slater, JM
    Slater, JD
    GASTROENTEROLOGY, 2004, 127 (05) : S189 - S193
  • [42] TANDEM CYCLES OF HIGH-DOSE CHEMOTHERAPY (HDC) SUPPORTED WITH G-CSF PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC)
    MEISENBERG, B
    MILLER, W
    MCMILLAN, R
    BLOOD, 1994, 84 (10) : A715 - A715
  • [43] EFFECT OF PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY FILGRASTIM (G-CSF) ON PLATELET RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY
    GRIGG, A
    BEGLEY, CG
    JUTTNER, CA
    SZER, J
    TO, LB
    MAHER, D
    MCGRATH, KM
    MORSTYN, G
    FOX, RM
    SHERIDAN, WP
    BONE MARROW TRANSPLANTATION, 1993, 11 : 23 - 29
  • [44] Split schedule reinfusion of G-CSF primed peripheral stem cells (PSC), but not CD34+ selected PSC enhances hematopoietic recovery in patients (PTS) following high-dose chemotherapy (HDCT).
    Somlo, G
    Sniecinkei, I
    Ahn, C
    Chow, W
    Hamasaki, V
    Leong, L
    Margoli, K
    Morgan, R
    Raschko, J
    Shibata, S
    Tetef, M
    Yon, Y
    Molina, A
    Forman, S
    Doroshow, J
    BLOOD, 1995, 86 (10) : 1531 - 1531
  • [45] EFFECT OF PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY FILGRASTIM (G-CSF) ON PLATELET RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY
    SHERIDAN, WP
    BEGLEY, CG
    JUTTNER, CA
    SZER, J
    TO, LB
    MAHER, D
    MCGRATH, KM
    MORSTYN, G
    FOX, RM
    LANCET, 1992, 339 (8794): : 640 - 644
  • [46] Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
    Halpern, Anna B.
    Rodriguez-Arboli, Eduardo
    Othus, Megan
    Garcia, Kelsey-Leigh A.
    Percival, Mary-Elizabeth M.
    Cassaday, Ryan D.
    Oehler, Vivian G.
    Becker, Pamela S.
    Appelbaum, Jacob S.
    Abkowitz, Janis L.
    Orozco, Johnnie J.
    Keel, Sioban B.
    Hendrie, Paul C.
    Scott, Bart L.
    Ghiuzeli, M. Cristina
    Estey, Elihu H.
    Walter, Roland B.
    BLOOD ADVANCES, 2023, 7 (17) : 4950 - 4961
  • [47] The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients
    F Lefrère
    S Zohar
    D Ghez
    R Delarue
    F Audat
    F Suarez
    O Hermine
    G Damaj
    N Maillard
    J A Ribeil
    M Azagury
    R Misbahi
    K Jondeau
    M Cavazzana-Calvo
    L Dal Cortivo
    B Varet
    Bone Marrow Transplantation, 2006, 37 : 725 - 729
  • [48] The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization:: results from a monocentric study of 82 patients
    Lefrère, F
    Zohar, S
    Ghez, D
    Delarue, R
    Audat, F
    Suarez, F
    Hermine, O
    Damaj, G
    Maillard, N
    Ribeil, JA
    Azagury, M
    Misbahi, R
    Jondeau, K
    Cavazzana-Calvo, M
    Cortivo, LD
    Varet, B
    BONE MARROW TRANSPLANTATION, 2006, 37 (08) : 725 - 729
  • [49] High dose chemotherapy (HDC) with G-CSF and peripheral blood stem cell support (PBSC) in advanced breast cancer (ABC)
    Longree, L
    Extra, JM
    Cuvier, C
    Marty, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 381 - 381
  • [50] PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION WITH CYCLOPHOSPHAMIDE, ADRIAMYCIN, 5-FLUROURACIL AND G-CSF - ABILITY TO SUPPORT MULTIPLE CYCLES OF HIGH-DOSE CHEMOTHERAPY
    PRINCE, HM
    IMRIE, K
    KEATING, A
    TRIP, K
    GOSS, PE
    CRUMP, M
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 755 - 755
12345